In our study, we evaluated the active and inactive forms of TGF-β1 and observed that TGF-β1 levels were decreased after 6 months of COVID-19 compared to the control group, and these levels remained decreased after 15 months of the disease. Here, TGFB1 is linked to COVID-19.